{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épilepsie partielle complexe : Questions médicales les plus fréquentes",
"headline": "Épilepsie partielle complexe : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épilepsie partielle complexe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Épilepsies partielles",
"url": "https://questionsmedicales.fr/mesh/D004828",
"about": {
"@type": "MedicalCondition",
"name": "Épilepsies partielles",
"code": {
"@type": "MedicalCode",
"code": "D004828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.360"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe",
"alternateName": "Epilepsy, Complex Partial",
"code": {
"@type": "MedicalCode",
"code": "D017029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Xiao-Rong Liu",
"url": "https://questionsmedicales.fr/author/Xiao-Rong%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Yong-Hong Yi",
"url": "https://questionsmedicales.fr/author/Yong-Hong%20Yi",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Jie Wang",
"url": "https://questionsmedicales.fr/author/Jie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Wei-Ping Liao",
"url": "https://questionsmedicales.fr/author/Wei-Ping%20Liao",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Association of Maryland Global Budget Revenue With Spending and Outcomes Related to Surgical Care for Medicare Beneficiaries With Cancer.",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35385085",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamasurg.2022.0135"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hospital Expenditures Under Global Budgeting and Single-Payer Financing: An Economic Analysis, 2021-2030.",
"datePublished": "2023-01-30",
"url": "https://questionsmedicales.fr/article/36714974",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/27551938231152750"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patient experience with hospital care following the Maryland global budget revenue model: A difference-in-difference analysis.",
"datePublished": "2024-08-06",
"url": "https://questionsmedicales.fr/article/39106261",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0308331"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Interactive Control in Budget Management on Innovation Performance of Enterprises: From the Perspective of Manager Role Stress.",
"datePublished": "2023-01-25",
"url": "https://questionsmedicales.fr/article/36767557",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20032190"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35843996",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40258-022-00747-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Épilepsie",
"item": "https://questionsmedicales.fr/mesh/D004827"
},
{
"@type": "ListItem",
"position": 6,
"name": "Épilepsies partielles",
"item": "https://questionsmedicales.fr/mesh/D004828"
},
{
"@type": "ListItem",
"position": 7,
"name": "Épilepsie partielle complexe",
"item": "https://questionsmedicales.fr/mesh/D017029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épilepsie partielle complexe - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épilepsie partielle complexe",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épilepsie partielle complexe",
"description": "Comment diagnostique-t-on l'épilepsie partielle complexe ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nPeut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Budgets&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épilepsie partielle complexe",
"description": "Quels sont les symptômes typiques des crises ?\nLes crises peuvent-elles affecter la mémoire ?\nComment se manifestent les comportements automatisés ?\nLes crises peuvent-elles être précédées d'aura ?\nLes symptômes peuvent-ils persister après la crise ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Budgets&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épilepsie partielle complexe",
"description": "Peut-on prévenir les crises d'épilepsie partielle complexe ?\nQuels sont les déclencheurs courants des crises ?\nL'éducation des proches est-elle importante ?\nLes activités physiques sont-elles sûres ?\nComment gérer le stress pour prévenir les crises ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Budgets&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épilepsie partielle complexe",
"description": "Quels médicaments sont couramment prescrits ?\nLa chirurgie est-elle une option de traitement ?\nQuelles sont les alternatives aux médicaments ?\nComment évaluer l'efficacité du traitement ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Budgets&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épilepsie partielle complexe",
"description": "Quelles sont les complications possibles de l'épilepsie ?\nL'épilepsie peut-elle affecter la vie sociale ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles entraîner des blessures graves ?\nComment les complications peuvent-elles être gérées ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Budgets&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épilepsie partielle complexe",
"description": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?\nL'âge influence-t-il le risque d'épilepsie ?\nLes maladies neurologiques augmentent-elles le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Budgets&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'épilepsie partielle complexe ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, l'EEG et l'imagerie cérébrale."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'EEG et l'IRM sont essentiels pour visualiser l'activité cérébrale et les anomalies."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer selon la localisation de l'activité épileptique."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les antécédents de crises et les facteurs déclenchants."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut se manifester chez les enfants, nécessitant une évaluation spécialisée."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes typiques des crises ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires, des hallucinations et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles affecter la mémoire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises peuvent entraîner des pertes de mémoire temporaires ou des confusions."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les comportements automatisés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements automatisés incluent des gestes répétitifs sans conscience de l'environnement."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles être précédées d'aura ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent une aura, un signe avant-coureur de la crise."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils persister après la crise ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue ou la confusion peuvent persister après la crise."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les crises d'épilepsie partielle complexe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il soit difficile de prévenir, éviter les déclencheurs connus peut aider."
}
},
{
"@type": "Question",
"name": "Quels sont les déclencheurs courants des crises ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, le manque de sommeil et l'alcool sont des déclencheurs fréquents."
}
},
{
"@type": "Question",
"name": "L'éducation des proches est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les proches sur les crises et les premiers secours est crucial."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités peuvent être sûres, mais il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir les crises ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation comme la méditation peuvent aider à gérer le stress."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticonvulsivants comme la carbamazépine et la lamotrigine sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée si les médicaments ne contrôlent pas les crises."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives aux médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies comportementales et la stimulation cérébrale peuvent être des options."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la fréquence des crises et les effets secondaires des médicaments."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant sommeil et gestion du stress, peut aider."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'épilepsie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les blessures lors des crises et des problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "L'épilepsie peut-elle affecter la vie sociale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des difficultés sociales et des stigmates associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de dépression ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes épileptiques présentent un risque plus élevé de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles entraîner des blessures graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chutes ou les accidents pendant une crise peuvent causer des blessures graves."
}
},
{
"@type": "Question",
"name": "Comment les complications peuvent-elles être gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge multidisciplinaire est essentielle pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les traumatismes crâniens et les infections cérébrales sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'épilepsie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'épilepsie peut survenir à tout âge, mais elle est plus fréquente chez les jeunes enfants et les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les maladies neurologiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques peuvent augmenter le risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme l'exposition à des toxines peuvent contribuer au risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut déclencher des crises chez certaines personnes épileptiques."
}
}
]
}
]
}
In 2014, Maryland initiated the global budget revenue (GBR) model, placing caps on total hospital expenditures across all care sites. The GBR program aims to reduce unnecessary utilization while maint...
To compare changes in spending, clinical outcomes, and acute care utilization through 4 years of the GBR program among Medicare beneficiaries who undergo cancer-directed surgery in Maryland vs matched...
Drawing from a matched pool of hospitals in Maryland (n = 35) and 24 control states with a similar timing of Medicaid expansion (n = 101), we identified Medicare beneficiaries from Maryland and contro...
Thirty-day episode spending, mortality, readmissions, and emergency department (ED) visits....
Relative to Medicare beneficiaries undergoing cancer surgery in control states (n = 4737; 3323 [70.1%] female; 571 [12.1%] dual-eligible; mean [SD] age 74.9 [6.5] years), patients in Maryland (n = 20 ...
Global budget revenue was not associated with changes in expenditures, ED utilization, or clinical outcomes after cancer-directed surgery through 4 years. There was a modest decline in 30-day readmiss...
U.S. hospitals provide large amounts of low-value care and devote inordinate resources to administration, while some hospitals leverage market power to realize large profits. Meanwhile, many rural and...
As a result of the success of Maryland's full risk capitated payment model experiment (Global Budget Revenue) in constraining healthcare costs, there is momentum for expanding the reach of such models...
Cross-sectional study using a difference-in-difference analysis to examine changes in patient experiences according to the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) dom...
A total of 844 hospitals were included. Compared to hospitals in non-GBR states, hospitals in GBR states experienced significant declines in the following HCAHPS domains: "would definitely recommend t...
These findings suggest there should be efforts made to ascertain and mitigate potential adverse effects of care transformation initiatives on patient experience. Patients are stakeholders and their in...
This study aimed to study the influence of the interactive budget on enterprise innovation performance from the perspective of managerial psychology, and to examine the mediating effect of managers' s...
There is a severe shortage of donor organs globally. There is growing interest in understanding how a 'soft opt-out' organ donation system could help bridge the supply and demand gap for donor organs....
A decision-analytic model was developed to estimate the incremental costs from a health system's perspective, quality-adjusted life-years (QALYs), and death averted of people who have kidney failure, ...
A 20% increase in organ donation rates could have a cost saving of 650 million Australian dollars (A$) and a 10,400-QALY gain. A 20% increase would avert more than 1500 deaths, while a 40% increase wo...
A 'soft opt-out' organ donation system would return a cost saving for the healthcare system, a net gain in QALYs, and prevention of a significant number of deaths. Advantageous budgetary impact is imp...
Gene therapy is known to be unaffordable to those who need it the most; however, evidence on the financial impact is limited....
This study aimed to estimate the budget impact and affordability of the gene therapy idecabtagene vicleucel for the treatment of adult patients with relapsed or refractory multiple myeloma (rrMM) in t...
A budget impact model was developed to estimate the budget impact to the US healthcare plan compared with bortezomib-based maintenance therapy. The target population size was based on a hypothetical 1...
An estimated 22 patients with rrMM each year would be eligible for idecabtagene vicleucel. The model projected the annual cost per patient in the first year as $19,449 and $517,528.13 for bortezomib a...
This study suggests that the high cost of the gene therapy idecabtagene vicleucel is justifiable due to the low number of rrMM patients....
The twin deficit hypothesis suggests that budget deficits are crucial factors leading to current account deficits, and substantial empirical evidence documents a significant positive statistical corre...
Priority setting in health directly impacts the general public as payers and final consumers, so the public preferences must be considered. The present study aimed to provide public preferences about ...
A choice-based survey method was used to assess the general public's preferences regarding 8 critical criteria with a societal aspect. One thousand sixty-four adult citizens of Tehran, Iran, participa...
Based on expressed participants' preferences, criteria of disease severity, age, daily care needs, Number of alternative interventions, individual's economic status, and diseases with absence from wor...
Iranian general public pays special attention to the criteria of equitable allocation, including patients' economic status, criteria with societal aspects such as absenteeism from work and the need fo...
To determine the budget impact of virtual care....
We conducted a budget impact analysis of virtual care from the perspective of a large teaching hospital in the Netherlands. Virtual care included remote monitoring of vital signs and three daily remot...
Net budget impact over 5 years was €2 090 000 for implementation in one ward, €410 000 for two wards and €-6 206 000 for the entire hospital. Costs/patient/day in the first year were €303 for implemen...
With present cost levels, virtual care only saves money if it is deployed at sufficient scale or if it can be designed such that the active involvement of health professionals is minimised. Taking a g...
Non-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to evaluate the potential cost-effectiveness of NPIs and the budget...
Five NPIs including usual care, lifestyle, strengthen exercise, relaxation, and diet therapy were selected based on the practice of hypertension management in China. A nine-state Markov model was cons...
Strengthen exercise was the most cost-effective intervention with a probability of 78.1% under the given WTP threshold. Our results were sensitive to the cost of interventions, and the utility of preh...
Strengthen exercise was a potential NPI that can be considered in priority for early management in prehypertensive population. Although early management can acquire medical cost saving, the related pr...